These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31526371)

  • 1. What will it take for the Global Plan priority countries in Sub-Saharan Africa to eliminate mother-to-child transmission of HIV?
    Goga AE; Dinh TH; Essajee S; Chirinda W; Larsen A; Mogashoa M; Jackson D; Cheyip M; Ngandu N; Modi S; Bhardwaj S; Chirwa E; Pillay Y; Mahy M
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):783. PubMed ID: 31526371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother-to-child HIV transmission (EMTCT) efforts.
    Drake AL; Thomson KA; Quinn C; Newman Owiredu M; Nuwagira IB; Chitembo L; Essajee S; Baggaley R; Johnson CC
    J Int AIDS Soc; 2019 Apr; 22(4):e25271. PubMed ID: 30958644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda.
    Mugwaneza P; Lyambabaje A; Umubyeyi A; Humuza J; Tsague L; Mwanyumba F; Mutabazi V; Nsanzimana S; Ribakare M; Irakoze A; Mutaganzwa E; Lombard C; Jackson D
    BMC Public Health; 2018 Nov; 18(1):1248. PubMed ID: 30419870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT.
    Goga AE; Dinh TH; Jackson DJ; Lombard CJ; Puren A; Sherman G; Ramokolo V; Woldesenbet S; Doherty T; Noveve N; Magasana V; Singh Y; Ramraj T; Bhardwaj S; Pillay Y;
    J Glob Health; 2016 Dec; 6(2):020405. PubMed ID: 27698999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis.
    Moyo F; Haeri Mazanderani A; Sherman GG; Kufa T
    S Afr Med J; 2022 Mar; 112(3):219-226. PubMed ID: 35380525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The geographic distribution of priority population groups for the elimination of mother-to-child transmission of HIV in South Africa.
    Moyo F; Haeri Mazanderani A; Kufa T; Sherman GG
    PLoS One; 2020; 15(4):e0231228. PubMed ID: 32267890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and effects of antiretroviral therapy coverage during pregnancy on mother-to-child transmission of HIV in Sub-Saharan Africa. Evidence from panel data analysis.
    Astawesegn FH; Stulz V; Conroy E; Mannan H
    BMC Infect Dis; 2022 Feb; 22(1):134. PubMed ID: 35135474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation.
    Zhang L; Tao Y; Woodring J; Rattana K; Sovannarith S; Rathavy T; Cheang K; Hossain S; Ferradini L; Deng S; Sokun C; Samnang C; Nagai M; Lo YR; Ishikawa N
    Int J Epidemiol; 2019 Aug; 48(4):1327-1339. PubMed ID: 30879066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operational issues and barriers to implementation of prevention of mother-to-child transmission of HIV (PMTCT) interventions in Sub-Saharan Africa.
    Aizire J; Fowler MG; Coovadia HM
    Curr HIV Res; 2013 Mar; 11(2):144-59. PubMed ID: 23432490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of HIV infection in women and children: a global perspective.
    Shetty AK
    Curr HIV Res; 2013 Mar; 11(2):81-92. PubMed ID: 23432485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.
    Dunning L; Gandhi AR; Penazzato M; Soeteman DI; Revill P; Frank S; Phillips A; Dugdale C; Abrams E; Weinstein MC; Newell ML; Collins IJ; Doherty M; Vojnov L; Fassinou Ekouévi P; Myer L; Mushavi A; Freedberg KA; Ciaranello AL
    J Int AIDS Soc; 2021 Jan; 24(1):e25651. PubMed ID: 33474817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000].
    Castetbon K; Leroy V; Spira R; Dabis F
    Sante; 2000; 10(2):103-13. PubMed ID: 10960807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient factors to target for elimination of mother-to-child transmission of HIV.
    Mnyani CN; Simango A; Murphy J; Chersich M; McIntyre JA
    Global Health; 2014 May; 10():36. PubMed ID: 24886029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards elimination of mother-to-child transmission of HIV in Ghana: an analysis of national programme data.
    Dako-Gyeke P; Dornoo B; Ayisi Addo S; Atuahene M; Addo NA; Yawson AE
    Int J Equity Health; 2016 Jan; 15():5. PubMed ID: 26759248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.